Skip to main content
. 2021 Sep;16(9):1345–1354. doi: 10.2215/CJN.01130121

Figure 3.

Figure 3.

Placebo-adjusted chronic yearly slopes from week 6 in the overall population and by baseline kidney function. Preservation of ≥0.75 ml/min per 1.73 m2 per year on eGFR slope predicts protection against CKD (9). Analysis was performed on the full analysis set. 95% CI, 95% confidence interval; KDIGO CKD, Kidney Disease Improving Global Outcomes in Chronic Kidney Disease; UACR, urinary albumin-to-creatinine ratio.